by 臺北榮民總醫院腫瘤醫學部
<p>『候診的你,是否感到焦慮呢？還是等的太久,無聊了呢？讓醫師們陪你聊聊天,一起健康好生活』 <br /> <br />『希望透過我們的節目,能帶給您更多的力量並給予更完善的衛教知識』 <br /> <br />身體的一言難盡,讓我們成為您的出口 <br /> <br /> <br/>Powered by <a href="https://firstory.me/zh">Firstory Hosting</a></p>
Language
🇨🇳
Publishing Since
7/25/2024
Email Addresses
1 available
Phone Numbers
0 available
March 31, 2025
<p>留言告訴我你對這一集的想法： <br />🎧 <strong>膽戰心驚！膽管癌的類型與治療——最新療法與健保新規解析</strong> <br />本集<strong>陳明晃醫師</strong>與<strong>膽道癌個管師宜演</strong>，共同討論膽道癌治療與台灣健保給付現況。帶你深入了解<strong>膽道癌的治療現況、免疫治療突破、以及最新的健保給付政策</strong>！ <br />🔍 <strong>你將聽到：</strong> <br />✅ <strong>膽道癌治療新趨勢</strong>：GC vs. GS化療方案有何不同？怎麼選擇最合適的治療？ <br />✅ <strong>免疫治療如何改變膽道癌治療策略</strong>：PD-1/PD-L1抑制劑如何提升存活率？副作用該如何處理？ <br />✅ <strong>標靶治療的精準時代</strong>：次世代基因定序（NGS）如何幫助患者獲得個人化療法？ <br />✅ <strong>重磅消息！健保給付最新變革</strong>：2024年2月1日起，台灣健保已經<strong>正式納入免疫治療（Durvalumab）合併GC化療</strong>作為<strong>膽道癌第一線治療</strong>！ <br />💡 <strong>為什麼這集不能錯過？</strong> <br />膽道癌一直是難以治療的癌症之一，而近年來，<strong>免疫治療的崛起帶來新希望</strong>，特別是<strong>健保納入Durvalumab + GC方案</strong>後，患者能夠減輕昂貴藥費負擔，提升治療可及性。但這項給付有什麼條件？適用哪些族群？治療成效如何？ <br />如果你正在關心膽道癌治療、健保政策或最新醫療趨勢，這集一定要收聽！ 🎙🔬<a href="https://open.firstory.me/user/clyo0u65407g501129ucresru/comments">https://open.firstory.me/user/clyo0u65407g501129ucresru/comments</a></p> <br /> <br/>Powered by <a href="https://firstory.me/zh">Firstory Hosting</a>
February 23, 2025
<p>留言告訴我你對這一集的想法： <br />本集節目邀請到台北榮民總醫院血液腫瘤科唐振育醫師與陳天華醫師來搭檔與各位觀眾暢聊局部晚期與復發鼻咽癌的治療,有別於頭頸癌, <br />在治療上的檢查該如何早期發現與預防,在什麼樣的環境裡是屬於高危險族群,讓醫師來跟您聊一聊 <br /> <br />『候診的你,是否感到焦慮呢？還是等的太久,無聊了呢？讓醫師們陪你聊聊天,一起健康好生活』 <br />『希望透過我們的節目,能帶給您更多的力量並給予更完善的衛教知識』 <br /> 身體的一言難盡,讓我們成為您的出口 <br /> </p> <br /> <br/>Powered by <a href="https://firstory.me/zh">Firstory Hosting</a>
January 3, 2025
<p>本集邀請台北榮民總醫院腫瘤醫學部陳三奇醫師來分享肝癌標靶治療及免疫治療優缺點與選擇 <br />陳醫師將分享 <strong>標靶治療</strong> 與 <strong>免疫治療</strong> 的優缺點，幫助患者及家屬了解這些療法如何選擇，並根據病情與生活需求做出最適合的決定。而健保給付不斷更新,最新相關給付條件也請門診諮詢醫師說明 <br /><strong>你將學到：</strong></p><ul><li>標靶治療與免疫治療的作用機制</li><li>不同療法在效果、風險與副作用上的差異</li><li>在多元治療選項中如何與醫師討論，找到最佳方案</li></ul><p>掌握肝癌治療的新希望！ <br /> <br />【候診的你 是否感到焦慮呢?還是等的太久，無聊了呢?讓醫師們陪你聊聊天一起健康好生活!】 <br /> <br /> <br /> <br />【生病讓人徬徨無助,希望透過我們的節目,能帶給您更多的力量並給予更完善的衛教知識】 <br />謝謝您的收聽 <br />如果有任何想與我們分享的，或者想了解的資訊 <br />可以掃描門診區QRCODE留言 <br /> <br />我們會於之後的PODCAST為您解答 <br /> <br />身體的一言難盡，讓我們成為您的出口】留言告訴我你對這一集的想法： <a href="https://open.firstory.me/user/clyo0u65407g501129ucresru/comments" target="_blank">https://open.firstory.me/user/clyo0u65407g501129ucresru/comments</a></p> <br /> <br/>Powered by <a href="https://firstory.me/zh">Firstory Hosting</a>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
